Why Is Dermata Therapeutics Stock Gaining Thursday?

On Thursday, Dermata Therapeutics Inc. (NASDAQ:DRMA) announced positive topline results from a cosmetic clinical study evaluating its recently launched skin renewal treatment, Tome Foundational Treatment. Following the announcement, the stock jumped nearly 34%. Study...